Back

The importance of distinct cardiac MRI regional analyses to assess the effects of cliramitug on amyloid depletion from the Phase 1b study NI006-101

30 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Heart failure redefined: hypertrophic cardiomyopathy and transthyretin amyloid cardiomyopathy precision treatments Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Fabian Aus Dem Siepen

University Hospital Heidelberg, Heidelberg (Germany)

6 More presentations in this session

Presentation thumbnail
Fewer adverse events reported in ATTR-CM patients treated with vutrisiran versus placebo: Post hoc safety analysis from HELIOS-B
Doctor S. Schwarting (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Building on the demonstrated functional benefit of tafamidis: association of TTR stabilisation with 6MWT outcomes in ATTR ACT
Associate Professor M. Crespo-Leiro (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Estimated glomerular filtration rate trajectories by transthyretin stabilisation status in ATTR-ACT
Doctor S. Perlini (Pavia, IT)
Abstract Slides
Presentation thumbnail
Long-term efficacy of vutrisiran in patients with variant transthyretin amyloid cardiomyopathy
Doctor T. Zaizen (Oita, JP)
Abstract Slides
Presentation thumbnail
Comprehensive assessment of disease status in ATTRwt-CM: Integrating serum transthyretin levels with clinical parameters using stabilizer therapy
Assistant Professor K. Yoshie (Matsumoto, JP)
Abstract Slides

Access the full session

Session thumbnail
Heart failure redefined: hypertrophic cardiomyopathy and transthyretin amyloid cardiomyopathy precision treatments

The Event

Event poster

ESC Congress 2026

30 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac MRI as a possible alternative to echocardiography for therapeutic response monitoring in ATTR cardiomyopathy: a multiparametric evaluation in patisiran treated patients
11 May 2023
thumbnail
Congress Presentation
Longitudinal evaluation of cardiac and extracardiac amyloid load in patients with AL and ATTR amyloidosis, measured by 124I-AT-01 PET/CT imaging
25 August 2023
thumbnail
Congress Presentation
Relative apical longitudinal strain: a powerful tool to predict outcomes in transthyretin amyloid cardiomyopathy
22 May 2023
thumbnail
Congress Presentation
Reduction of extracellular volume and reverse cardiac remodeling during sacubitril/valsartan therapy assessed by cardiac magnetic resonance in patients with heart failure (REMODELING CMR-HF)
6 May 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources